nderstanding the effect of probiotics consumption in improving the Atopic Dermatitis disease
- Conditions
- Health Condition 1: L208- Other atopic dermatitis
- Registration Number
- CTRI/2024/06/068558
- Lead Sponsor
- nique Biotech Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Patients with age of two to eighteen years diagnosed with atopic dermatitis (mild to moderate (SCORAD of 50).
1)Patient with associated (inflammatory and infectious) skin diseases
2)Patients using oral corticosteroids or monoclonal antibodies or immunosuppressants within 30 days before enrolment.
3)Use of phototherapy for AD in the previous 2 months.
4)Probiotic intake in the previous 2 months.
5)Systemic antibiotic treatment in the previous 4 days; fever
6)Patients in whom any of the study products is contraindicated.
7)Patients who have participated in research studies with medicinal products during the previous 3 months.
8)patients with gluten or lactose intolerance or inflammatory bowel disease (Crohn disease or ulcerative colitis)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method